TY - JOUR AU - Melmed, S. AU - Melmed, S. PY - 2006 DA - 2006// TI - Medical progress: Acromegaly. [Review] [102 refs] JO - New England Journal of Medicine VL - 355 UR - https://doi.org/10.1056/NEJMra062453 DO - 10.1056/NEJMra062453 ID - Melmed2006 ER - TY - JOUR AU - Chanson, P. AU - Salenave, S. PY - 2008 DA - 2008// TI - Acromegaly JO - Orphanet J Rare Dis VL - 3 UR - https://doi.org/10.1186/1750-1172-3-17 DO - 10.1186/1750-1172-3-17 ID - Chanson2008 ER - TY - JOUR AU - Colao, A. AU - Ferone, D. AU - Marzullo, P. AU - Lombardi, G. PY - 2004 DA - 2004// TI - Systemic complications of acromegaly: epidemiology, pathogenesis, and management JO - Endocr Rev VL - 25 UR - https://doi.org/10.1210/er.2002-0022 DO - 10.1210/er.2002-0022 ID - Colao2004 ER - TY - JOUR AU - Holdaway, I. M. AU - Rajasoorya, C. PY - 1999 DA - 1999// TI - Epidemiology of acromegaly JO - Pituitary VL - 2 UR - https://doi.org/10.1023/A:1009965803750 DO - 10.1023/A:1009965803750 ID - Holdaway1999 ER - TY - CHAP PY - 2004 DA - 2004// BT - Somavert: Summary of Product Characteristics ID - ref5 ER - TY - CHAP PY - 2001 DA - 2001// BT - Undertaking systematic reviews of research on effectiveness: CRDs guidance for those carrying out or commisioning reviews. 4 ID - ref6 ER - TY - JOUR AU - Trainer, P. J. AU - Drake, W. M. AU - Katznelson, L. AU - Freda, P. U. AU - Herman-Bonert, V. AU - Lely, A. J. v. a. n. d. e. r. AU - Dimaraki, E. V. AU - Stewart, P. M. AU - Friend, K. E. AU - Vance, M. L. PY - 2000 DA - 2000// TI - Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant JO - The New England journal of medicine VL - 342 UR - https://doi.org/10.1056/NEJM200004203421604 DO - 10.1056/NEJM200004203421604 ID - Trainer2000 ER - TY - JOUR AU - Lely, A. J. v. a. n. d. e. r. AU - Hutson, R. K. AU - Trainer, P. J. AU - Besser, G. M. AU - Barkan, A. L. AU - Katznelson, L. AU - Klibanski, A. AU - Herman-Bonert, V. AU - Melmed, S. AU - Vance, M. L. PY - 2001 DA - 2001// TI - Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist[see comment] JO - Lancet VL - 358 UR - https://doi.org/10.1016/S0140-6736(01)06844-1 DO - 10.1016/S0140-6736(01)06844-1 ID - Lely2001 ER - TY - JOUR AU - Sesmilo, G. AU - Fairfield, W. P. AU - Katznelson, L. AU - Pulaski, K. AU - Freda, P. U. AU - Bonert, V. AU - Dimaraki, E. AU - Stavrou, S. AU - Vance, M. L. AU - Hayden, D. PY - 2002 DA - 2002// TI - Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant JO - The Journal of clinical endocrinology and metabolism VL - 87 UR - https://doi.org/10.1210/jcem.87.4.8364 DO - 10.1210/jcem.87.4.8364 ID - Sesmilo2002 ER - TY - JOUR AU - Fairfield, W. P. AU - Sesmilo, G. AU - Katznelson, L. AU - Pulaski, K. AU - Freda, P. U. AU - Stavrou, S. AU - Kleinberg, D. AU - Klibanski, A. PY - 2002 DA - 2002// TI - Effects of a growth hormone receptor antagonist on bone markers in acromegaly JO - Clinical endocrinology VL - 57 UR - https://doi.org/10.1046/j.1365-2265.2002.01624.x DO - 10.1046/j.1365-2265.2002.01624.x ID - Fairfield2002 ER - TY - JOUR AU - Biering, H. AU - Saller, B. AU - Bauditz, J. AU - Pirlich, M. AU - Rudolph, B. AU - Johne, A. AU - Buchfelder, M. AU - Mann, K. AU - Droste, M. AU - Schreiber, I. PY - 2006 DA - 2006// TI - Elevated transaminases during medical treatment of acromegaly: a review of the German pegvisomant surveillance experience and a report of a patient with histologically proven chronic mild active hepatitis JO - European Journal of Endocrinology VL - 154 UR - https://doi.org/10.1530/eje.1.02079 DO - 10.1530/eje.1.02079 ID - Biering2006 ER - TY - JOUR AU - Parkinson, C. AU - Burman, P. AU - Messig, M. AU - Trainer, P. J. AU - Parkinson, C. AU - Burman, P. AU - Messig, M. AU - Trainer, P. J. PY - 2007 DA - 2007// TI - Gender, body weight, disease activity, and previous radiotherapy influence the response to pegvisomant JO - Journal of Clinical Endocrinology & Metabolism VL - 92 UR - https://doi.org/10.1210/jc.2006-1412 DO - 10.1210/jc.2006-1412 ID - Parkinson2007 ER - TY - JOUR AU - Paisley, A. N. AU - O'Callaghan, C. J. AU - Lewandowski, K. C. AU - Parkinson, C. AU - Roberts, M. E. AU - Drake, W. M. AU - Monson, J. P. AU - Trainer, P. J. AU - Randeva, H. S. AU - Paisley, A. N. PY - 2006 DA - 2006// TI - Reductions of circulating matrix metalloproteinase 2 and vascular endothelial growth factor levels after treatment with pegvisomant in subjects with acromegaly JO - Journal of Clinical Endocrinology & Metabolism VL - 91 UR - https://doi.org/10.1210/jc.2005-2589 DO - 10.1210/jc.2005-2589 ID - Paisley2006 ER - TY - JOUR AU - Parkinson, C. AU - Flyvbjerg, A. AU - Trainer, P. J. PY - 2004 DA - 2004// TI - High levels of 150-kDa insulin-like growth factor binding protein three ternary complex in patients with acromegaly and the effect of pegvisomant-induced serum IGF-I normalization JO - Growth hormone & IGF research: official journal of the Growth Hormone Research Society and the International IGF Research Society VL - 14 UR - https://doi.org/10.1016/j.ghir.2003.08.004 DO - 10.1016/j.ghir.2003.08.004 ID - Parkinson2004 ER - TY - JOUR AU - Parkinson, C. AU - Kassem, M. AU - Heickendorff, L. AU - Flyvbjerg, A. AU - Trainer, P. J. PY - 2003 DA - 2003// TI - Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal JO - The Journal of clinical endocrinology and metabolism VL - 88 UR - https://doi.org/10.1210/jc.2003-030772 DO - 10.1210/jc.2003-030772 ID - Parkinson2003 ER - TY - JOUR AU - Colao, A. AU - Pivonello, R. AU - Auriemma, R. S. AU - De Martino, M. C. AU - Bidlingmaier, M. AU - Briganti, F. AU - Tortora, F. AU - Burman, P. AU - Kourides, I. A. AU - Strasburger, C. J. PY - 2006 DA - 2006// TI - Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance JO - European Journal of Endocrinology VL - 154 UR - https://doi.org/10.1530/eje.1.02112 DO - 10.1530/eje.1.02112 ID - Colao2006 ER - TY - JOUR AU - Jehle, S. AU - Reyes, C. M. AU - Sundeen, R. E. AU - Freda, P. U. AU - Jehle, S. AU - Reyes, C. M. AU - Sundeen, R. E. AU - Freda, P. U. PY - 2005 DA - 2005// TI - Alternate-day administration of pegvisomant maintains normal serum insulin-like growth factor-I levels in patients with acromegaly JO - Journal of Clinical Endocrinology & Metabolism VL - 90 UR - https://doi.org/10.1210/jc.2004-1967 DO - 10.1210/jc.2004-1967 ID - Jehle2005 ER - TY - JOUR AU - Feenstra, J. AU - de Herder, W. W. AU - ten Have, S. M. AU - Beld, A. W. v. a. n. d. e. n. AU - Feelders, R. A. AU - Janssen, J. A. AU - Lely, A. J. v. a. n. d. e. r. AU - Feenstra, J. AU - de Herder, W. W. AU - ten Have, S. M. T. H. PY - 2005 DA - 2005// TI - Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly[erratum appears in Lancet. 2005 May;365(9471):1620] JO - Lancet VL - 365 UR - https://doi.org/10.1016/S0140-6736(05)63011-5 DO - 10.1016/S0140-6736(05)63011-5 ID - Feenstra2005 ER - TY - JOUR AU - Jorgensen, J. O. AU - Feldt-Rasmussen, U. AU - Frystyk, J. AU - Chen, J. W. AU - Kristensen, L. O. AU - Hagen, C. AU - Orskov, H. AU - Jorgensen, J. O. L. AU - Feldt-Rasmussen, U. AU - Frystyk, J. PY - 2005 DA - 2005// TI - Cotreatment of acromegaly with a somatostatin analog and a growth hormone receptor antagonist JO - Journal of Clinical Endocrinology & Metabolism VL - 90 UR - https://doi.org/10.1210/jc.2005-0531 DO - 10.1210/jc.2005-0531 ID - Jorgensen2005 ER - TY - JOUR AU - Pivonello, R. AU - Galderisi, M. AU - Auriemma, R. S. AU - De Martino, M. C. AU - Galdiero, M. AU - Ciccarelli, A. AU - D'Errico, A. AU - Kourides, I. AU - Burman, P. AU - Lombardi, G. PY - 2007 DA - 2007// TI - Treatment with growth hormone receptor antagonist in acromegaly: effect on cardiac structure and performance JO - Journal of Clinical Endocrinology & Metabolism VL - 92 UR - https://doi.org/10.1210/jc.2006-1587 DO - 10.1210/jc.2006-1587 ID - Pivonello2007 ER - TY - JOUR AU - Schreiber, I. AU - Buchfelder, M. AU - Droste, M. AU - Forssmann, K. AU - Mann, K. AU - Saller, B. AU - Strasburger, C. J. AU - the, G. P. I. AU - Schreiber, I. AU - Buchfelder, M. PY - 2007 DA - 2007// TI - Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study JO - European Journal of Endocrinology VL - 156 UR - https://doi.org/10.1530/eje.1.02312 DO - 10.1530/eje.1.02312 ID - Schreiber2007 ER - TY - JOUR AU - Parkinson, C. AU - Drake, W. M. AU - Wieringa, G. AU - Yates, A. P. AU - Besser, G. M. AU - Trainer, P. J. AU - Parkinson, C. AU - Drake, W. M. AU - Wieringa, G. AU - Yates, A. P. PY - 2002 DA - 2002// TI - Serum lipoprotein changes following IGF-I normalization using a growth hormone receptor antagonist in acromegaly JO - Clinical Endocrinology VL - 56 UR - https://doi.org/10.1046/j.1365-2265.2002.01460.x DO - 10.1046/j.1365-2265.2002.01460.x ID - Parkinson2002 ER - TY - JOUR AU - Parkinson, C. AU - Whatmore, A. J. AU - Yates, A. P. AU - Drake, W. M. AU - Brabant, G. AU - Clayton, P. E. AU - Trainer, P. J. AU - Parkinson, C. AU - Whatmore, A. J. AU - Yates, A. P. PY - 2003 DA - 2003// TI - The effect of pegvisomant-induced serum IGF-I normalization on serum leptin levels in patients with acromegaly JO - Clinical Endocrinology VL - 59 UR - https://doi.org/10.1046/j.1365-2265.2003.01795.x DO - 10.1046/j.1365-2265.2003.01795.x ID - Parkinson2003 ER - TY - JOUR AU - Barkan, A. L. AU - Burman, P. AU - Clemmons, D. R. AU - Drake, W. M. AU - Gagel, R. F. AU - Harris, P. E. AU - Trainer, P. J. AU - Lely, A. J. v. a. n. d. e. r. AU - Vance, M. L. PY - 2005 DA - 2005// TI - Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant JO - The Journal of clinical endocrinology and metabolism VL - 90 UR - https://doi.org/10.1210/jc.2005-0331 DO - 10.1210/jc.2005-0331 ID - Barkan2005 ER - TY - JOUR AU - Paisley, A. N. AU - Hayden, K. AU - Ellis, A. AU - Anderson, J. AU - Wieringa, G. AU - Trainer, P. J. PY - 2007 DA - 2007// TI - Pegvisomant interference in GH assays results in underestimation of GH levels JO - European Journal of Endocrinology VL - 156 UR - https://doi.org/10.1530/eje.1.02341 DO - 10.1530/eje.1.02341 ID - Paisley2007 ER - TY - CHAP PY - 2007 DA - 2007// BT - Therapeutic Development Assessment Pegvisomant (Somavert®) ID - ref26 ER - TY - JOUR AU - Bates, A. S. AU - Van't, H. W. AU - Jones, J. M. AU - Clayton, R. N. PY - 1993 DA - 1993// TI - An audit of outcome of treatment in acromegaly JO - Q J Med VL - 86 ID - Bates1993 ER - TY - JOUR AU - Orme, S. M. AU - McNally, R. J. AU - Cartwright, R. A. AU - Belchetz, P. E. PY - 1998 DA - 1998// TI - Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group JO - J Clin Endocrinol Metab VL - 83 ID - Orme1998 ER - TY - JOUR AU - Kauppinen-Makelin, R. AU - Sane, T. AU - Reunanen, A. AU - Valimaki, M. J. AU - Niskanen, L. AU - Markkanen, H. AU - Loyttyniemi, E. AU - Ebeling, T. AU - Jaatinen, P. AU - Laine, H. PY - 2005 DA - 2005// TI - A nationwide survey of mortality in acromegaly JO - J Clin Endocrinol Metab VL - 90 UR - https://doi.org/10.1210/jc.2004-1381 DO - 10.1210/jc.2004-1381 ID - Kauppinen-Makelin2005 ER - TY - JOUR AU - Ayuk, J. AU - Clayton, R. N. AU - Holder, G. AU - Sheppard, M. C. AU - Stewart, P. M. AU - Bates, A. S. PY - 2004 DA - 2004// TI - Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly JO - J Clin Endocrinol Metab VL - 89 UR - https://doi.org/10.1210/jc.2003-031584 DO - 10.1210/jc.2003-031584 ID - Ayuk2004 ER - TY - JOUR AU - Rowles, S. V. AU - Prieto, L. AU - Badia, X. AU - Shalet, S. M. AU - Webb, S. M. AU - Trainer, P. J. PY - 2005 DA - 2005// TI - Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire JO - J Clin Endocrinol Metab VL - 90 UR - https://doi.org/10.1210/jc.2004-1565 DO - 10.1210/jc.2004-1565 ID - Rowles2005 ER - TY - JOUR AU - Kauppinen-Makelin, R. AU - Sane, T. AU - Sintonen, H. AU - Markkanen, H. AU - Valimaki, M. J. AU - Loyttyniemi, E. AU - Niskanen, L. AU - Reunanen, A. AU - Stenman, U. H. AU - Kauppinen-Makelin, R. PY - 2006 DA - 2006// TI - Quality of life in treated patients with acromegaly JO - Journal of Clinical Endocrinology & Metabolism VL - 91 UR - https://doi.org/10.1210/jc.2006-0676 DO - 10.1210/jc.2006-0676 ID - Kauppinen-Makelin2006 ER - TY - JOUR AU - Biermasz, N. R. AU - van Thiel, S. W. AU - Pereira, A. M. AU - Hoftijzer, H. C. AU - van Hemert, A. M. AU - Smit, J. W. AU - Romijn, J. A. AU - Roelfsema, F. PY - 2004 DA - 2004// TI - Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess JO - J Clin Endocrinol Metab VL - 89 UR - https://doi.org/10.1210/jc.2004-0669 DO - 10.1210/jc.2004-0669 ID - Biermasz2004 ER - TY - JOUR AU - Hua, S. C. AU - Yan, Y. H. AU - Chang, T. C. AU - Hua, S. C. AU - Yan, Y. H. AU - Chang, T. C. PY - 2006 DA - 2006// TI - Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly JO - European Journal of Endocrinology VL - 155 UR - https://doi.org/10.1530/eje.1.02292 DO - 10.1530/eje.1.02292 ID - Hua2006 ER - TY - JOUR AU - Webb, S. M. AU - Badia, X. AU - Surinach, N. L. PY - 2006 DA - 2006// TI - Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study JO - European Journal of Endocrinology VL - 155 UR - https://doi.org/10.1530/eje.1.02214 DO - 10.1530/eje.1.02214 ID - Webb2006 ER - TY - JOUR AU - Trepp, R. AU - Everts, R. AU - Stettler, C. AU - Fischli, S. AU - Allemann, S. AU - Webb, S. M. AU - Christ, E. R. PY - 2005 DA - 2005// TI - Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL) JO - Clin Endocrinol (Oxf) VL - 63 UR - https://doi.org/10.1111/j.1365-2265.2005.02307.x DO - 10.1111/j.1365-2265.2005.02307.x ID - Trepp2005 ER - TY - STD TI - British National Formulary: 2007, Accessed June 2007, [http://www.bnf.org/bnf/] UR - http://www.bnf.org/bnf/ ID - ref37 ER - TY - STD TI - NHS reference costs 2005-06, Mental Health Services: Inpatient Data. MHIPA2 adult: acute care. 2007, Ref Type: Data File ID - ref38 ER - TY - CHAP AU - Moore, D. AU - Meads, C. AU - Roberts, L. AU - Song, F. PY - 2001 DA - 2001// TI - The effectiveness of somatostatin analogues in the treatment of acromegaly. Report 37, West Midlands Health Technology Assessment Collaboration BT - Department of Public Health & Epidemiology, University of Birmingham ID - Moore2001 ER - TY - CHAP PY - 2006 DA - 2006// BT - Pegvisomant (Somavert, Pfizer) for treatment of acromegaly ID - ref40 ER - TY - JOUR AU - Didoni, G. AU - Grottol, S. AU - Gasco, V. AU - Battistini, M. AU - Ferone, D. AU - Giusti, M. AU - Ragazzoni, F. AU - Ruffo, P. AU - Ghigo, E. AU - Minuto, F. PY - 2004 DA - 2004// TI - Cost-of-illness study in acromegalic patients in Italy JO - J Endocrinol Invest VL - 27 UR - https://doi.org/10.1007/BF03345306 DO - 10.1007/BF03345306 ID - Didoni2004 ER - TY - JOUR AU - Bonert, V. S. AU - Kennedy, L. AU - Petersenn, S. AU - Barkan, A. AU - Carmichael, J. AU - Melmed, S. PY - 2008 DA - 2008// TI - Lipodystrophy in patients with acromegaly receiving pegvisomant JO - J Clin Endocrinol Metab VL - 93 UR - https://doi.org/10.1210/jc.2008-0833 DO - 10.1210/jc.2008-0833 ID - Bonert2008 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6823/9/20/prepub UR - http://www.biomedcentral.com/1472-6823/9/20/prepub ID - ref43 ER -